Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10362435 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
Conditions: Dementia;   Parkinson Disease
Intervention: Drug: Quetiapine

Indicates status has not been verified in more than two years